These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 12203168
21. Cytomegalovirus antigenemia and outcomes of patients undergoing allogeneic peripheral blood stem cell transplantation: effects of long-term high-dose acyclovir prophylaxis and preemptive ganciclovir treatment. Hazar V, Ugur A, Colak D, Saba R, Tezcan G, Kupesiz A, Karadogan I, Gultekin M, Yesilipek A, Undar L. Jpn J Infect Dis; 2006 Aug; 59(4):216-21. PubMed ID: 16936338 [Abstract] [Full Text] [Related]
23. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Parody R, Martino R, Rovira M, Vazquez L, Vázquez MJ, de la Cámara R, Blazquez C, Fernández-Avilés F, Carreras E, Salavert M, Jarque I, Martín C, Martínez F, López J, Torres A, Sierra J, Sanz GF, Infectious/Non-infectious Complications Subcommittee of the Grupo Español de Trasplante Hematopoyético (GETH). Biol Blood Marrow Transplant; 2006 Jul; 12(7):734-48. PubMed ID: 16785063 [Abstract] [Full Text] [Related]
24. Early predictors of transplant-related mortality (TRM) after allogeneic bone marrow transplants (BMT): blood urea nitrogen (BUN) and bilirubin. Bacigalupo A, Oneto R, Bruno B, Soracco M, Lamparelli T, Gualandi F, Occhini D, Raiola A, Mordini N, Berisso G, Bregante S, Dini G, Lombardi A, Lint MV, Brand R. Bone Marrow Transplant; 1999 Sep; 24(6):653-9. PubMed ID: 10490732 [Abstract] [Full Text] [Related]
25. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia. Kim HJ, Min WS, Cho BS, Eom KS, Kim YJ, Min CK, Lee S, Cho SG, Jin JY, Lee JW, Kim CC. Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755 [Abstract] [Full Text] [Related]
26. Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir. Ippoliti C, Morgan A, Warkentin D, van Besien K, Mehra R, Khouri I, Giralt S, Gajewski J, Champlin R, Andersson B, Przepiorka D. Bone Marrow Transplant; 1997 Sep; 20(6):491-5. PubMed ID: 9313883 [Abstract] [Full Text] [Related]
27. Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. The Fukuoka Bone Marrow Transplantation Group. Takenaka K, Gondo H, Tanimoto K, Nagafuji K, Fujisaki T, Mizuno S, Miyamoto T, Okamura T, Hayashi S, Eto T, Osaki K, Yamasaki K, Shibuya T, Harada N, Teshima T, Matsuishi E, Minematsu T, Minamishima Y, Harada M, Niho Y. Bone Marrow Transplant; 1997 Feb; 19(3):241-8. PubMed ID: 9028553 [Abstract] [Full Text] [Related]
28. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program. Kimura F, Sato K, Kobayashi S, Ikeda T, Sao H, Okamoto S, Miyamura K, Mori S, Akiyama H, Hirokawa M, Ohto H, Ashida H, Motoyoshi K, Japan Marrow Donor Program. Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834 [Abstract] [Full Text] [Related]
29. Randomized controlled trial of sequential intravenous and oral ganciclovir versus prolonged intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in high-risk cytomegalovirus-seronegative liver transplant recipients with cytomegalovirus-seropositive donors. Winston DJ, Busuttil RW. Transplantation; 2004 Jan 27; 77(2):305-8. PubMed ID: 14742998 [Abstract] [Full Text] [Related]
30. Cytomegalovirus immunity and T lymphocytes in bone marrow donors and acute graft-versus-host disease. Gratama JW, Fibbe WE, Naipal AM, Slats J, Stijnen T, D'Amaro J, Bolhuis RL, The TH, Janssen J. Bone Marrow Transplant; 1986 Dec 27; 1(2):141-6. PubMed ID: 2844332 [Abstract] [Full Text] [Related]
31. Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia. Passweg JR, Rowlings PA, Atkinson KA, Barrett AJ, Gale RP, Gratwohl A, Jacobsen N, Klein JP, Ljungman P, Russell JA, Schaefer UW, Sobocinski KA, Vossen JM, Zhang MJ, Horowitz MM. Bone Marrow Transplant; 1998 Jun 27; 21(12):1231-8. PubMed ID: 9674857 [Abstract] [Full Text] [Related]
32. Donor cytomegalovirus seropositivity and the risk of leukemic relapse after reduced-intensity transplants. Nachbaur D, Clausen J, Kircher B. Eur J Haematol; 2006 May 27; 76(5):414-9. PubMed ID: 16480430 [Abstract] [Full Text] [Related]
33. Impact of cytomegalovirus match on survival after cardiac and lung transplantation. Bonatti H, Tabarelli W, Ruttmann E, Kafka R, Larcher C, Höfer D, Klaus A, Laufer G, Geltner C, Margreiter R, Müller L, Antretter H. Am Surg; 2004 Aug 27; 70(8):710-4. PubMed ID: 15328806 [Abstract] [Full Text] [Related]
34. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy. Yakoub-Agha I, Mesnil F, Kuentz M, Boiron JM, Ifrah N, Milpied N, Chehata S, Esperou H, Vernant JP, Michallet M, Buzyn A, Gratecos N, Cahn JY, Bourhis JH, Chir Z, Raffoux C, Socié G, Golmard JL, Jouet JP, French Society of Bone Marrow Transplantation and Cell Therapy. J Clin Oncol; 2006 Dec 20; 24(36):5695-702. PubMed ID: 17116940 [Abstract] [Full Text] [Related]
35. Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis. Russell JA, Turner AR, Larratt L, Chaudhry A, Morris D, Brown C, Quinlan D, Stewart D. Biol Blood Marrow Transplant; 2007 Mar 20; 13(3):299-306. PubMed ID: 17317583 [Abstract] [Full Text] [Related]
36. Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers? Ringdén O, Schaffer M, Le Blanc K, Persson U, Hauzenberger D, Abedi MR, Olerup O, Ljungman P, Remberger M. Biol Blood Marrow Transplant; 2004 Feb 20; 10(2):128-34. PubMed ID: 14750078 [Abstract] [Full Text] [Related]
37. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources. Walker CM, van Burik JA, De For TE, Weisdorf DJ. Biol Blood Marrow Transplant; 2007 Sep 20; 13(9):1106-15. PubMed ID: 17697973 [Abstract] [Full Text] [Related]
38. Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors. Shah T, Lai WK, Mutimer D. Transpl Infect Dis; 2005 Jun 20; 7(2):57-62. PubMed ID: 16150091 [Abstract] [Full Text] [Related]
39. Cytomegalovirus infections in allogeneic stem cell recipients after reduced-intensity or myeloablative conditioning assessed by quantitative PCR and pp65-antigenemia. Schetelig J, Oswald O, Steuer N, Radonic A, Thulke S, Held TK, Oertel J, Nitsche A, Siegert W. Bone Marrow Transplant; 2003 Oct 20; 32(7):695-701. PubMed ID: 13130317 [Abstract] [Full Text] [Related]
40. Outcomes of transplantation with partial T-cell depletion of matched or mismatched unrelated or partially matched related donor bone marrow in children and adolescents with leukemias. Bunin N, Aplenc R, Leahey A, Magira E, Grupp S, Pierson G, Monos D. Bone Marrow Transplant; 2005 Jan 20; 35(2):151-8. PubMed ID: 15531896 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]